Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

Made in the USA, a new daily oral weight-loss pill from Eli Lilly won't require cold storage and is expected to hit markets ...

Eli Lilly, the maker of Ozempic, has developed a weight loss pill that could work as well. The new weight loss pill, ...

Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the ...

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

Brazil nuts, walnuts, cashews, pistachios, almonds, hazelnuts, pecans, and peanuts are calorie- and nutrient-dense additions ...

It's little secret that America has a weight problem. For decades, Americans have embraced and abandoned countless ...

Of course, that is easier said than done, which is why drugs ... rapid weight loss (see “How they work”, below) also leads to notable declines in muscle mass. For instance, a 2021 study ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent years, a new study says ... between 2018 and 2021 to $5.8 billion in ...

Novo Nordisk remains an industry leader, and currently offers both a 2.7% dividend yield and compelling value that can work ...